10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
PFIZER INC | |||
Ticker: PFE Fiscal Year: 2009 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Revenues | $ 50,009 | 48,296 | 48,418 |
| Costs and expenses: | |||
| Cost of sales [1] | 8,888 [1] | 8,112 | 11,239 |
| Selling, informational and administrative expenses [1] | 14,875 | 14,537 | 15,626 |
| Research and development expenses [1] | 7,845 | 7,945 | 8,089 |
| Amortization of intangible assets | 2,877 | 2,668 | 3,128 |
| Acquisition-related in-process research and development charges | 68 | 633 | 283 |
| Restructuring charges and certain acquisition-related costs | 4,337 | 2,675 | 2,534 |
| Other (income)/deductions-net | 292 | 2,032 | (1,759) |
| Income from continuing operations before provision for taxes on income | 10,827 | 9,694 | 9,278 |
| Provision for taxes on income | 2,197 | 1,645 | 1,023 |
| Income from continuing operations | 8,630 | 8,049 | 8,255 |
| Discontinued operations-net of tax | 14 | 78 | (69) |
| Net income before allocation to noncontrolling interests | 8,644 | 8,127 | 8,186 |
| Less: Net income attributable to noncontrolling interests | 9 | 23 | 42 |
| Net income attributable to Pfizer Inc. | 8,635 | 8,104 | 8,144 |
| Earnings per common share-basic | |||
| Income from continuing operations attributable to Pfizer Inc. common shareholders | 1.23 | 1.19 | 1.19 |
| Discontinued operations-net of tax | 0.00 | 0.01 | (0.01) |
| Net income attributable to Pfizer Inc. common shareholders | 1.23 | 1.20 | 1.18 |
| Earnings per common share-diluted | |||
| Income from continuing operations attributable to Pfizer Inc. common shareholders | 1.23 | 1.19 | 1.18 |
| Discontinued operations-net of tax | 0.00 | 0.01 | (0.01) |
| Net income attributable to Pfizer Inc. common shareholders | 1.23 | 1.20 | 1.17 |
| Weighted-average shares-basic | 7,007 | 6,727 | 6,917 |
| Weighted-average shares-diluted | 7,045 | 6,750 | 6,939 |
| [1] Exclusive of amortization of intangible assets except as disclosed in Note 1L. Significant Accounting Policies: Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets. | |||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
PFIZER INC | |||
Ticker: PFE Fiscal Year: 2009 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
| Operating Activities | |||
| Net income before allocation to noncontrolling interests | $ 8,644 | 8,127 | 8,186 |
| Adjustments to reconcile net income before noncontrolling interests to net cash provided by operating activities: | |||
| Depreciation and amortization | 4,757 | 5,090 | 5,200 |
| Share-based compensation expense | 349 | 384 | 437 |
| Acquisition-related in-process research and development charges | 68 | 633 | 283 |
| Certain intangible asset impairments and other associated non-cash charges | 0 | 0 | 2,220 |
| Gains on disposals | (670) | (14) | (326) |
| (Gains)/losses on sales of discontinued operations | 0 | (6) | 168 |
| Deferred taxes from continuing operations | (9,582) | (1,331) | (2,788) |
| Other non-cash adjustments | 504 | 496 | 773 |
| Changes in assets and liabilities, net of acquisitions and divestitures: | |||
| Accounts receivable | (472) | 195 | (320) |
| Inventories | 1,631 | 294 | 720 |
| Other assets | (867) | (538) | (647) |
| Accounts payable and accrued liabilities | 1,695 | 3,797 | 1,509 |
| Taxes | 9,454 | 647 | (2,002) |
| Other liabilities | 1,076 | 464 | (60) |
| Net cash provided by operating activities | 16,587 | 18,238 | 13,353 |
| Investing Activities | |||
| Purchases of property, plant and equipment | (1,205) | (1,701) | (1,880) |
| Purchases of short-term investments with original maturities greater than 90 days | (35,331) | (35,705) | (25,426) |
| Proceeds from redemptions and sales of short-term investments with original maturities greater than 90 days | 42,364 | 27,883 | 23,053 |
| Proceeds from redemptions and sales of short-term investments with original maturities of 90 days or less-net | 5,775 | 7,913 | 7,235 |
| Purchases of long-term investments | (6,888) | (9,357) | (1,635) |
| Proceeds from redemptions and sales of long-term investments | 6,504 | 1,009 | 172 |
| Acquisitions, net of cash acquired | (43,123) | (1,184) | (464) |
| Other investing activities | 632 | (1,693) | (260) |
| Net cash (used in)/provided by investing activities | (31,272) | (12,835) | 795 |
| Financing Activities | |||
| Increase in short-term borrowings-net | 32,033 | 40,119 | 3,155 |
| Principal payments on short-term borrowings-net | (34,969) | (37,264) | (764) |
| Proceeds from issuances of long-term debt | 24,023 | 605 | 2,573 |
| Principal payments on long-term debt | (967) | (1,053) | (64) |
| Purchases of common stock | 0 | (500) | (9,994) |
| Cash dividends paid | (5,548) | (8,541) | (7,975) |
| Other financing activities | (91) | 74 | 459 |
| Net cash provided by/(used in) financing activities | 14,481 | (6,560) | (12,610) |
| Effect of exchange-rate changes on cash and cash equivalents | 60 | (127) | 41 |
| Net (decrease)/ increase in cash and cash equivalents | (144) | (1,284) | 1,579 |
| Cash and cash equivalents at beginning of year | 2,122 | 3,406 | |
| Cash and cash equivalents at end of year | 1,978 | 2,122 | 3,406 |
| Supplemental Cash Flow Information: | |||
| Non-cash transactions-Acquisition of Wyeth, treasury stock issued | 23,303 | ||
| Cash paid during the period for: | |||
| Income taxes | 2,300 | 2,252 | 5,617 |
| Interest | 935 | 782 | 643 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2009 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets | ||
| Cash and cash equivalents | $ 1,978 | 2,122 |
| Short-term investments | 23,991 | 21,609 |
| Accounts receivable, less allowance for doubtful accounts: 2009-$176; 2008-$190 | 14,645 | 8,958 |
| Short-term loans | 1,195 | 824 |
| Inventories | 12,403 | 4,381 |
| Current deferred tax assets and other current assets | 6,962 | 5,034 |
| Assets held for sale | 496 | 148 |
| Total current assets | 61,670 | 43,076 |
| Long-term investments and loans | 13,122 | 11,478 |
| Property, plant and equipment, less accumulated depreciation | 22,780 | 13,287 |
| Goodwill | 42,376 | 21,464 |
| Identifiable intangible assets, less accumulated amortization | 68,015 | 17,721 |
| Noncurrent deferred tax assets and other noncurrent assets | 4,986 | 4,122 |
| Total assets | 212,949 | 111,148 |
| Liabilities and Shareholders' Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2009-$27; 2008-$937 | 5,469 | 9,320 |
| Accounts payable | 4,370 | 1,751 |
| Dividends payable | 1,454 | 2,159 |
| Income taxes payable | 10,107 | 656 |
| Accrued compensation and related items | 2,242 | 1,667 |
| Current deferred tax liabilities and other current liabilities | 13,583 | 11,456 |
| Total current liabilities | 37,225 | 27,009 |
| Long-term debt | 43,193 | 7,963 |
| Pension benefit obligations | 6,392 | 4,235 |
| Postretirement benefit obligations | 3,243 | 1,604 |
| Noncurrent deferred tax liabilities | 17,839 | 2,959 |
| Other taxes payable | 9,000 | 6,568 |
| Other noncurrent liabilities | 5,611 | 3,070 |
| Total liabilities | 122,503 | 53,408 |
| Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2009-1,511; 2008-1,804 | 61 | 73 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 2009-8,869; 2008-8,863 | 443 | 443 |
| Additional paid-in capital | 70,497 | 70,283 |
| Employee benefit trusts | (333) | (425) |
| Treasury stock, shares at cost; 2009-799; 2008-2,117 | (21,632) | (57,391) |
| Retained earnings | 40,426 | 49,142 |
| Accumulated other comprehensive income/(expense) | 552 | (4,569) |
| Total Pfizer Inc. shareholders' equity | 90,014 | 57,556 |
| Equity attributable to noncontrolling interests | 432 | 184 |
| Total shareholders' equity | 90,446 | 57,740 |
| Total liabilities and shareholders' equity | 212,949 | 111,148 |
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |